KEEPsAKE 2KEEPsAKE 1risankizumabPsoriatic ArthritisuveitisPsApsoriasisdactylitisperipheral arthritis
…rse events through 100 weeks.Results Overall, in KEEPsAKE 1 and KEEPsAKE 2, 412/483 (85.3%) and 181/224 (80.8%) of patients randomised to …
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: KEEPsAKE 2 ×
KEEPsAKE 2
This institution is selected. Its supporting articles are shown below.